United States Biopsy Market will be USD 14 Billion by 2025 - PowerPoint PPT Presentation

About This Presentation
Title:

United States Biopsy Market will be USD 14 Billion by 2025

Description:

United States Biopsy Market will cross US$ 17 Billion by the year 2024. US Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver and Thyroid), Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, FUJIFILM Holdings Corporation, Medtronic plc., Hologic, Inc – PowerPoint PPT presentation

Number of Views:41

less

Transcript and Presenter's Notes

Title: United States Biopsy Market will be USD 14 Billion by 2025


1
United States Biopsy Market
United States Biopsy Market
2
Report Description and Highlights
Liquid biopsies offer a secure and reliable way
to collect samples, to treat invasively and to
diagnose more rapidly, resulting in increased
demand for these tools. It is a rapid process
that usually involves simply drawing blood,
extracting nucleic acids from the blood plasma,
and amplifying molecular targets to allow the
identified biomarkers. Increasing awareness of
minimally invasive procedures, favorable
government initiatives and the presence of an
immense cancer population base are key drivers of
market growth. United States Biopsy Market is
predicted to surpass USD 14 Billion by the end of
the year 2025. Renub Research report titled
United States Biopsy Market, Volume Forecast
by Segments (Breast, Prostate, Lung, Liver
,Thyroid, Kidney, Colorectal and Skin) Cancer,
Companies (C. R. Bard, Inc., Becton, Dickinson
and Company, B. Braun Melsungen AG, Cardinal
Health, Inc., Olympus Corporation, FUJIFILM
Holdings Corporation, Medtronic plc., Hologic,
Inc) provides a complete analysis of the United
States Biopsy Market and Volume.
United States Biopsy Market
3
United States Biopsy Market
The major factors that fuel the United States
liquid biopsy market are increasing prevalence
of different types of cancer, non-invasive
techniques such as liquid biopsy tests are in
more demand in United States, comfort of patient,
detection of tumor in early stages, rising
healthcare infrastructure, increasing per capita
income and increasing awareness regarding liquid
biopsy in United States. The key obstacles
against United States growth in the market for
liquid biopsy are the lack of reimbursements and
constantly changing regulations for
laboratory-developed tests leading to growing
costs of new tests and delays in market
availability, low specificity and sensitivity.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lunited-states-biopsy-testing-market-and-volume-a
nalysis-to-2020-511-p.php
United States Biopsy Market
4
United States Biopsy Market
Market Summary By Segments Different types of
cancer are being examined in this biopsy market
Liver Cancer Biopsy, Thyroid Cancer Biopsy,
Kidney Cancer Biopsy, Colorectal Cancer Biopsy,
Skin Cancer Biopsy, Lung Cancer Biopsy, Prostate
Cancer Biopsy and Breast Cancer Biopsy. This
study provides a multi-factorial overview of why
the rate of biopsy in the United States is
growing by a different type of cancer biopsy
test. By Companies This report included all top
key players analysis Hologic, Inc, Medtronic
plc, FUJIFILM Holdings Corporation, Olympus
Corporation, Cardinal Health, Inc., B. Braun
Melsungen AG, Becton, Dickinson and Company and
C. R. Bard, Inc.
United States Biopsy Market
5
Key Topics Covered in United States Biopsy Market
  • Key Topics Covered
  •   Introduction
  • 2.    Research Methodology
  • 3.    Executive Summary
  • 4.    United States Biopsy Market Volume
  • 4.1    Market Forecast4.2    Volume Forecast
  • 5.    United States Biopsy Share
  • 5.1    Market Share Forecast5.2    Volume
    Share Forecast

United States Biopsy Market
6
Key Topics Covered in United States Biopsy Market
6.    Segment United States Biopsy Market 6.1
   Prostate Cancer Biopsy 6.2    Breast Cancer
Biopsy6.3    Lung Cancer Biopsy 6.4    Liver
Cancer Biopsy6.5    Thyroid Cancer Biopsy 6.6
   Kidney Cancer Biopsy6.7    Colon Rectum
Cancer Biopsy 6.8    Melanoma Skin Cancer
Biopsy 7.    Company Analysis 7.1    Becton,
Dickinson Company 7.2    B. Braun Melsungen
AG (Germany)7.3    Cardinal Health, Inc. 7.4
   Olympus Corporation (Japan)7.5    Boston
Scientific Corporation (U.S.) 7.6    Medtronic
Plc.7.7    Hologic, Inc.
United States Biopsy Market
7
Key Topics Covered in United States Biopsy Market
8.    Growth Factors 8.1    Inadequate Screening
Tests for Particular Cancers8.2    Demand for
Minimally-Invasive Biopsy Techniques8.3
   Advancement in Biopsy Techniques 9.
   Challenges 9.1    Reimbursement Issues9.2
   Limitations
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlunited-states-biopsy-testing-market-and-volume
-analysis-to-2020-511-p.php
United States Biopsy Market
8
United States Biopsy Market
Browse Related Report Global biopsy device
market Global Liquid Biopsy Market Contact
Us Tel 1-678-302-0700 (US),
91-120-421-9822 (INDIA) Email info_at_renub.com
United States Biopsy Market
Write a Comment
User Comments (0)
About PowerShow.com